|
|
|
|
Crohn's Disease: Inflammatory Bowel Diseases: Merck Manual Home Edition
Side effects are more common with sulfasalazine than with any of the other aminosalicylates Corticosteroids - Prednisone Diabetes mellitus, high blood pressure, cataracts, osteoporosis; thinning of skin, mental problems Diabetes and high blood pressure more likely to occur in people with other risk factors - Budesonide Diabetes mellitus, high blood pressure, cataracts,...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, QUARZAN to SYPRINE
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS QUARZAN to SYPRINE Trade Name Generic QUARZAN *Clidinium QUESTRAN Cholestyramine QUINAGLUTE Quinidine RAXAR Grepafloxacin REBETRON Ribavirin RECOMBIVAX HB Hepatitis B vaccine REGITINE Phentolamine REGLAN Metoclopramide RELAFEN Nabumetone RELENZA Zanamivir REOPRO Abciximab REQUIP Ropinirole...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Abciximab to Butorphanol
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Abciximab to Butorphanol Generic Trade Name Abciximab REOPRO Acarbose PRECOSE Acebutolol SECTRAL Acetaminophen TYLENOL Acetazolamide DIAMOX Acetohexamide DYMELOR Acetohydroxamic acid LITHOSTAT Acetophenazine TINDAL Acetylcysteine MUCOMYST ACTH See Corticotropin Acyclovir ZOVIRAX Adenosine ADENOCARD...
|
|
|
http://www.fda.gov/cder/orange/appendix_a.txt
4, ACETAMINOPHEN PHENAPHEN-650 W/ CODEINE, ACETAMINOPHEN PHENAZINE, PHENDIMETRAZINE TARTRATE PHENAZINE-35, PHENDIMETRAZINE TARTRATE PHENDIMETRAZINE TARTRATE, PHENDIMETRAZINE TARTRATE PHENERGAN FORTIS, PROMETHAZINE HYDROCHLORIDE PHENERGAN PLAIN, PROMETHAZINE HYDROCHLORIDE PHENERGAN VC W/ CODEINE, CODEINE PHOSPHATE PHENERGAN VC, PHENYLEPHRINE HYDROCHLORIDE PHENERGAN W/ CODEINE, CODEINE...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, QUARZAN to SYPRINE
Trade Names of Some Commonly Used Drugs TRADE AND GENERIC NAMES OF COMMONLY USED DRUGS QUARZAN to SYPRINE Trade Name Generic QUARZAN *Clidinium QUESTRAN Cholestyramine QUINAGLUTE Quinidine RAXAR Grepafloxacin REBETRON Ribavirin RECOMBIVAX HB Hepatitis B vaccine REGITINE Phentolamine REGLAN Metoclopramide RELAFEN Nabumetone RELENZA Zanamivir REOPRO Abciximab REQUIP Ropinirole...
|
|
|
THE MERCK MANUAL OF GERIATRICS, App. III, Trade Names of Some Commonly Used Drugs, Abciximab to Butorphanol
Trade Names of Some Commonly Used Drugs GENERIC AND TRADE NAMES OF COMMONLY USED DRUGS Abciximab to Butorphanol Generic Trade Name Abciximab REOPRO Acarbose PRECOSE Acebutolol SECTRAL Acetaminophen TYLENOL Acetazolamide DIAMOX Acetohexamide DYMELOR Acetohydroxamic acid LITHOSTAT Acetophenazine TINDAL Acetylcysteine MUCOMYST ACTH See Corticotropin Acyclovir ZOVIRAX Adenosine ADENO...
|
|
|
DOCUMENT INFORMATION PAGE
Rx only DESCRIPTION Budesonide, the active ingredient of RHINOCORT AQUA ® Nasal Spray, is an antiinflammatory synthetic corticosteroid
Its structural formula is: Budesonide is a white to off- white, odorless powder that is practically insoluble in water and in heptane, sparingly soluble in ethanol, and freely soluble in chloroform
Budesonide is...
author: CDER User
|
|
|
DOCUMENT INFORMATION PAGE page 2
author: CDER User
|
|
|
DOCUMENT INFORMATION PAGE page 1
author: CDER User
|
|
|
Prescription and Over-the-Counter Drug Product List: 9/2003
ADDITIONS/DELETIONS FOR PRESCRIPTION DRUG PRODUCT LIST ACETAMINOPHEN; HYDROCODONE BITARTRATE SOLUTION; ORAL HYDROCODONE BITARTRATE AND ACETAMINOPHEN >A> + MIKART 325MG/15ML;7.5MG/15ML N40482 001 SEP 25, 2003 SEP NEWA ACETAMINOPHEN; OXYCODONE HYDROCHLORIDE TABLET; ORAL >A> OXYCODONE AND ACETAMINOPHEN >A> AA WATSON LABS 325MG;7.5MG N40535 001 SEP 05, 2003 SEP NEWA >A> AA 325MG;10MG...
author: AUTHOR
|
|
|
20746_Rhinocort.htm
Food and Drug Administration • Center for Drug Evaluation and Research Approval Package Search Rhinocort Aqua (Budesonide) Nasal Spray Company:- AstraZeneca Application No.:- 20-746 Approval Date:-10/01/1999 - Approval Letter(s) - Printed Labeling - Medical Review(s)- Part 1 - Part 2 - Chemistry Review(s) - Environmental Assessment - Pharmacology Review(s)...
author: Paul Stauffer
|
|
|
DOCUMENT INFORMATION PAGE
Rx only DESCRIPTION Budesonide, the active component of PULMICORT TURBUHALER 200 mcg, is a corticosteroid designated chemically as (RS)- 11b, 16a, 17,21- Tetrahydroxypregna- 1,4diene- 3,20- dione cyclic 16,17- acetal with butyraldehyde
Budesonide is provided as a mixture of two epimers (22R and 22S)
CLINICAL PHARMACOLOGY Budesonide is an anti- inflammatory...
author: 599
|
|
|
DOCUMENT INFORMATION PAGE page 36
author: 599
|
|
|
DOCUMENT INFORMATION PAGE page 28
author: 599
|
|
|
DOCUMENT INFORMATION PAGE page 27
author: 599
|
|
|
DOCUMENT INFORMATION PAGE page 26
author: 599
|
|
|
DOCUMENT INFORMATION PAGE page 25
author: 599
|
|
|
http://www.fda.gov/cder/ogd/rld/RLD_LABELING_APPROVED_FEB_1999.HTML
Firm Date BRETHINE Terbutaline Sulfate Tablet 17-849 032 Novartis Pharms 2-Feb-1999 CHLOROMYCETIN Chloramphenicol Opth Ointment 50-156 038 Parkedale 3-Feb-1999 PRILOSEC Omeprazole Delayed-Release Capsule 19-810 057 Astra Merck 3-Feb-1999 TRANSDERM-NITRO Nitroglycerin Transdermal System 20-144 018 Novartis Pharms 3-Feb-1999 PRIMAXIN Cilastatin Sodium/Imipenem Injection 50-587 50-630...
|
|
|
FDA Drug Approvals List October 2001
- Drug Approvals for October 2001 Definitions and Notes Original New Drug Applications Original Application #: 021356 Approval Date: 26-OCT-01 Trade Name: VIREAD Chemical Type: 1 Therapeutic Potential: P Dosage Form: TABLET Applicant: GILEAD SCIENCES INC Active Ingredient(s): TENOFOVIR DISOPROXIL FUMARATE OTC/RX Status: RX Indication(s): For use in combination with other...
|
|
|
C:\Windows\Desktop\Team Leader Detail\Team leader notes\Pulmicortre\ supules_TLmemo.doc
Clinical Team Leader Review Memorandum Memorandum to: sNDA 20- 929 SE8- 013 file Product: Pulmicort® Respules TM (Budesonide Inhalation Suspension) Memo Date: February 12, 2003 Memo From: Lydia I
OVERVIEW The NDA for Budesonide Inhalation Suspension (BIS), PULMICORT® Respules TM was originally submitted on November 18, 1997
The Written Request required 2...
author: Lydia McClain
|
|
|
C:\Windows\Desktop\Team Leader Detail\Team leader notes\Pulmicortre\ supules_TLmemo.doc page 1
author: Lydia McClain
|
|
|
27292REVIEWInsF-InsB
ASTRAZENECA NOT JUST A PHARMACEUTICAL COMPANY ANNUAL REVIEW 2001 AstraZeneca Annual Review 2001 Key achievements 01 SALES OF $16.5 BILLION, UP 8%* OPERATING PROFIT OF $4.2 BILLION, UP 6%* EARNINGS PER SHARE OF $1.77, UP 11% SHARE BUY- BACK PROGRAMME EXTENDED BY AN ADDITIONAL $2 BILLION PROGRESS WITH RANGE OF PROMISING MEGABRANDS DRIVES TRANSFORMATION STRATEGY NEXIUM ACHIEVES FULL...
author: macuser
duplicates:
http://www.astrazeneca.com/annualrep2001/pdf/third.pdf
|
|
|
Contents Vol. 21, No. 3, 2001
Contents Editorial Policies and Procedures for Submitted Original Research iii Clinical Use Combination Chemotherapy with Docetaxel and Carboplatin for Advanced Non- Small Cell Lung Cancer 161- 168 W Schuette, I Bork, B Wollschlaeger, S Schaedlich Gabapentin and the Prophylaxis of Bipolar Disorders in Patients Intolerant to Lithium 169- 174 MC Mauri, V Laini, ME Scalvini, A Omboni,...
author: Adis International Limited
subject: Clinical Drug Investigation
|
|
|
http://www.fda.gov/cder/ogd/rld/20233s9.pdf
DESCRIPTION Budesonide, the active component of Rhinocort ® Nasal Inhaler, is an anti- inflammatory glucocorticosteroid
Budesonide is provided as a mixture of two epimers (22R and 22S)
CLINICAL PHARMACOLOGY Budesonide is a glucocorticosteroid having a potent glucocorticoid and weak mineralocorticoid activity
Budesonide is a mixture of two...
|
|
|
http://www.fda.gov/cder/ogd/rld/20233s9.pdf page 11
|
